[13] An additional important effect of GLP-1, is inhibition of glucagon secretion at glucose levels above fasting levels
10.1038/cddis.2017.28 Summary Keywords GLP-1, oral delivery, vagal afferents, diabetes, obesity, peptide Citation New RRC, Bogus M, Travers GN, Hahn U, Vaiceliunaite A, Burnet M, Wang JH and Wen H (2024) Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
Some of our patients are found to be deficient in Vitamin B12, and through our physician prescribing appropriate vitamin supplementation, some individuals note an improvement in energy level, she says
In a recent study published in the journal Frontiers in Nutrition , researchers examined nutrient intake when using a glucagon-like peptide 1 receptor agonist (GLP-1RA)
The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model
Eating nutrient-dense, balanced meals, even if small, can significantly reduce fatigue and support your metabolism